Clinical Trials Logo

Clinical Trial Summary

Use lay language.

The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.


Clinical Trial Description

Protocol description

Visit D0

- patient inclusion after informed signed consent

- clinical exam

- blood sampling (magnesium dosage)

- questionnaires (neuropathic pain and quality of life)

- daily self-evaluation on neuropathic pain scale (Week0 to Week5)

D8 : first intake of study drug (magnesium or placebo)

Visit Week5:

- questionnaires (neuropathic pain and quality of life)

- blood sampling (magnesium dosage)

- clinical exam ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01121653
Study type Interventional
Source University Hospital, Clermont-Ferrand
Contact
Status Completed
Phase Phase 4
Start date March 2006
Completion date June 2008